Health Care & Life Sciences » Biotechnology | Aduro Biotech Inc.

Aduro Biotech Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
828.00
13,389.00
72,979.00
50,681.00
17,239.00
15,087
Cost of Goods Sold (COGS) incl. D&A
129.00
240.00
-
-
-
-
Gross Income
699.00
13,149.00
-
-
-
-
SG&A Expense
15,235.00
32,267.00
85,820.00
111,722.00
107,528.00
95,263
EBIT
14,536.00
19,118.00
13,564.00
63,593.00
94,274.00
85,129
Unusual Expense
-
3,553.00
26,077.00
8,270.00
12,179.00
16,231
Non Operating Income/Expense
147.00
946.00
161.00
40.00
218.00
64
Interest Expense
1,371.00
2,395.00
-
-
-
-
Pretax Income
16,054.00
17,014.00
39,308.00
69,684.00
103,227.00
96,140
Income Tax
-
-
99.00
21,464.00
11,364.00
783
Consolidated Net Income
16,054.00
17,014.00
39,209.00
91,148.00
91,863.00
95,357
Net Income
16,054.00
17,014.00
39,209.00
91,148.00
91,863.00
95,357
Net Income After Extraordinaries
16,054.00
17,014.00
39,209.00
91,148.00
91,863.00
95,357
Net Income Available to Common
16,054.00
17,014.00
39,209.00
91,148.00
91,863.00
95,357
EPS (Basic)
0.57
0.61
0.88
1.40
1.26
1.21
Basic Shares Outstanding
28,042.80
28,042.80
44,706.40
65,200.80
72,901.20
78,812.40
EPS (Diluted)
0.57
0.61
0.88
1.40
1.26
1.21
Diluted Shares Outstanding
28,042.80
28,042.80
44,706.40
65,200.80
72,901.20
78,812.40
EBITDA
14,407.00
18,878.00
12,841.00
61,041.00
90,289.00
80,176
Non-Operating Interest Income
-
-
494.00
2,219.00
3,444.00
5,284

About Aduro Biotech

View Profile
Address
740 Heinz Avenue
Berkeley California 94710
United States
Employees -
Website http://www.aduro.com
Updated 07/08/2019
Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The firm's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.